newsfilter
← Latest News
GlobeNewswire·

Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported finan